Catipay, Anastacio G.

HRN: 25 01 14  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/27/2024
05/03/2024
IV
500mg
Q8
Intraabdominal Infection
Waiting Final Action 
04/27/2024
CEFTRIAXONE 1G (VIAL)
04/27/2024
05/03/2024
IV
2gm
OD
Intraabdominal Infection
Waiting Final Action 
05/09/2024
RIFAXIMIN 200MG (TAB)
05/09/2024
05/12/2024
PO
200mg
Tid
Hepatomegaly
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: